HTA

HTA Co., Ltd. (hereinafter referred to as HTA), as a holding company of China Isotope & Radiation Corporation under the China National Nuclear Corporation, is a national high-tech enterprise integrating the research and development, production, sales, and services of nuclear technology application products. Its product and business scope covers multiple fields including radiopharmaceuticals, radiolabeled compounds, nuclear medicine services, radiation sources, tracers, and medical devices. Adhering to the mission of "developing nuclear medicine for the benefit of humanity" and aiming to be "a global leader in nuclear medicine development," HTA practices its core values of "responsibility, safety, innovation, and collaboration." With a customer-centric approach, HTA continuously innovates, reforms, strengthens its core competitiveness, and expands and optimizes the nuclear technology application industry.